—
C+
C+ The full Closelook — membership. Open the C+ overview

Medacta Group SA (MOVE.SW) — the peer cohort

As of 2026-09-18 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Medacta Group SA ranks 8 of 8 in its cohort on the Closelook composite (47/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
MOVE.SW Medacta Group SA 47 10 57 32 warn 38%
DXCM DexCom Inc 66 86 80 35 bull 5%
SECT-B.ST Sectra AB (publ) 58 67 65 11 bull 15.3%
SNN Smith & Nephew SNATS Inc 56 22 56 73 warn 25.4%
SOON.SW Sonova H Ag 55 79 72 54 bull 5.2%
CEVI.ST CellaVision AB 54 64 69 31 bull 12.2%
SYK Stryker Corporation 52 21 66 43 bear 28.9%
BION.SW BB Biotech AG 74 74 96 81 info 8.2%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-18

Quick answers

Who are Medacta Group SA's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: DexCom Inc (DXCM), Sectra AB (publ) (SECT-B.ST), Smith & Nephew SNATS Inc (SNN), Sonova H Ag (SOON.SW), CellaVision AB (CEVI.ST), Stryker Corporation (SYK), BB Biotech AG (BION.SW).

How does MOVE.SW score against its peers?

Medacta Group SA's composite reads 47/100, ranking 8 of 8 in its cohort as of 2026-09-18; the cohort's highest composite is BB Biotech AG at 74/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Medical Devices. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.